JULIE KACZOR: Open Payments
NPI 1114911625 · TOWSON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 33 payments from 11 companies in 2025. Trend: 2023 $693 · 2024 $875 · 2025 $779
Food & beverage: $779
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $193 |
| Novo Nordisk Inc | 11 | $137 |
| Lilly USA, LLC | 2 | $103 |
| ABBVIE INC. | 4 | $76 |
| Exact Sciences Corporation | 3 | $63 |
| Merck Sharp & Dohme LLC | 2 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| PFIZER INC. | 2 | $42 |
| Amgen Inc. | 1 | $30 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: AIRSUPRA, MOUNJARO, Cologuard Collection Kit, Rybelsus, CAPVAXIVE, Ozempic, JARDIANCE, VRAYLAR.
Industry payments across MD — which companies pay providers there.
